Invention Grant
![[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds](/docs/US/2019-11-19/US10478424B2/abs.jpg.600x600.jpg)
- Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
-
Application No.: US16042116Application Date: 2018-07-23
-
Publication No.: US10478424B2Publication Date: 2019-11-19
- Inventor: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Gary Greenblatt
- Main IPC: A61K31/4196
- IPC: A61K31/4196 ; A61K31/437 ; A61K31/4427 ; A61K45/06 ; C07D249/00 ; C07D471/04
![[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds](/abs-image/US/2019/11/19/US10478424B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed are compounds of Formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
Public/Granted literature
- US20180325874A1 [1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS Public/Granted day:2018-11-15
Information query
